SLC5A2 and Hypomagnesemia: Similarly, Saha et al. [143] reported a clinical case of a patient with T2DM presenting with symptomatic hypomagnesemia attributed to excessive renal Mg loss, in whom a sustained improvement in Mg levels was observed after initiation of SGLT2 inhibitors, which allowed for a reduction in the dose of daily supplements.